https://scholars.lib.ntu.edu.tw/handle/123456789/469993
標題: | Ligand-dependent activation of EphA4 signaling regulates the proteolysis of amyloid precursor protein through a Lyn-mediated pathway | 作者: | Lai W.-B. Wang B.-J. Hu M.-K. WEN-MING HSU Her G.M. Liao Y.-F. |
公開日期: | 2014 | 出版社: | Humana Press Inc. | 卷: | 49 | 期: | 2 | 起(迄)頁: | 1055-1068 | 來源出版物: | Molecular Neurobiology | 摘要: | Alzheimer's disease is the most common dementia afflicting the elderly in modern society. This disease arises from the neurotoxicity elicited by abnormal aggregates of amyloid-β (Aβ) protein. Such aggregates form through the cleavage of amyloid precursor protein (APP) by β-secretase and the subsequent proteolysis of the APP C-terminal fragment (APP-βCTF or C99) by γ-secretase to yield Aβ and APP intracellular domain (AICD). Recent evidence suggests that C99 and AICD may exert harmful effects on cells, suggesting that the proteolytic products of APP, including Aβ, C99, and AICD, could play a pivotal role in neuronal viability. Here, we demonstrate that ligand-activated EphA4 signaling governs the proteostasis of C99, AICD, and Aβ, without significantly affecting γ-secretase activity. EphA4 induced accumulation of C99 and AICD through a Lyn-dependent pathway; activation of this pathway triggered phosphorylation of EphA4, resulting in positive feedback of C99 and AICD proteostasis. Inhibition of EphA4 by dasatinib, a receptor tyrosine kinase inhibitor, effectively suppressed C99 and AICD accumulation. Furthermore, EphA4 signaling controlled C99 and AICD proteolysis through the ubiquitin-proteasome system. In conclusion, we have identified an EphA4-Lyn pathway that is essential for the metabolism of APP and its proteolytic derivatives, thereby providing novel pharmacological targets for the development of anti-Aβ therapeutics for AD. ? 2013 Springer Science+Business Media. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896549076&doi=10.1007%2fs12035-013-8580-x&partnerID=40&md5=cc249065b8422383e82c488e695964c6 https://scholars.lib.ntu.edu.tw/handle/123456789/469993 |
ISSN: | 0893-7648 | DOI: | 10.1007/s12035-013-8580-x | SDG/關鍵字: | amyloid beta protein; amyloid precursor protein; amyloid precursor protein C99; amyloid precursor protein intracellular domain; dasatinib; ephrin receptor A4; gamma secretase; proteasome; protein kinase Lyn; ubiquitin; unclassified drug; amyloid precursor protein; ephrin receptor A4; ligand; lyn protein-tyrosine kinase; protein tyrosine kinase; article; cell strain HEK293; controlled study; embryo; enzyme activity; human; human cell; implantable cardioverter defibrillator; ligand binding; neuropathology; positive feedback; protein aggregation; protein degradation; protein function; protein homeostasis; protein phosphorylation; receptor upregulation; signal transduction; cell culture; genetics; HEK293 cell line; metabolism; physiology; T lymphocyte; Amyloid beta-Protein Precursor; Cells, Cultured; HEK293 Cells; Humans; Ligands; Proteolysis; Receptor, EphA4; Signal Transduction; src-Family Kinases; T-Lymphocytes |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。